These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12673615)

  • 21. [How long should drug therapy be continued for Alzheimer disease?].
    Nakamura Y
    Seishin Shinkeigaku Zasshi; 2009; 111(1):43-8. PubMed ID: 19378499
    [No Abstract]   [Full Text] [Related]  

  • 22. [Administration of symptom-relieving drugs in Alzheimer disease is beneficial].
    Nordberg A; Eriksdotter-Jönhagen M; Garlind A; Grut M; Freund-Levi Y; Cornelius C; Ekström A; Fastbom J; Sedvall M; Viitanen M
    Lakartidningen; 2006 Feb 8-14; 103(6):369-71. PubMed ID: 16536040
    [No Abstract]   [Full Text] [Related]  

  • 23. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 24. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 26. Current issues in dementia pharmacotherapy.
    Daiello LA
    Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIGN guideline for the management of patients with dementia.
    Connelly PJ; James R
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):14-6. PubMed ID: 16353165
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholinesterase inhibitor use in geriatric outpatients with dementia.
    Linnebur SA; Ruscin JM
    Am J Health Syst Pharm; 2005 May; 62(9):923-6. PubMed ID: 15851498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug therapy of Alzheimer dementia].
    Skausig OB; Laugesem LP; Jensen T
    Ugeskr Laeger; 2003 Jul; 165(29):2899; author reply 2899-900. PubMed ID: 12908363
    [No Abstract]   [Full Text] [Related]  

  • 30. Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules.
    Prescrire Int; 2009 Feb; 18(99):19. PubMed ID: 19391277
    [No Abstract]   [Full Text] [Related]  

  • 31. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholinesterase inhibitors from plants.
    Mukherjee PK; Kumar V; Mal M; Houghton PJ
    Phytomedicine; 2007 Apr; 14(4):289-300. PubMed ID: 17346955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial.
    Maruyama M; Tomita N; Iwasaki K; Ootsuki M; Matsui T; Nemoto M; Okamura N; Higuchi M; Tsutsui M; Suzuki T; Seki T; Kaneta T; Furukawa K; Arai H
    J Am Geriatr Soc; 2006 May; 54(5):869-71. PubMed ID: 16696770
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969
    [No Abstract]   [Full Text] [Related]  

  • 35. Are cholinesterase inhibitors more than symptomatic treatments for Alzheimer disease?
    Relkin N
    Alzheimer Dis Assoc Disord; 2006; 20(2 Suppl 1):S2. PubMed ID: 16772753
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of advanced Alzheimer's disease with cholinesterase inhibitors.
    Korczyn AD
    Alzheimers Dement; 2008 Sep; 4(5):371-2. PubMed ID: 18790465
    [No Abstract]   [Full Text] [Related]  

  • 38. Intra-operative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors.
    Jones PM; Soderman RM
    Anaesthesia; 2007 Feb; 62(2):201. PubMed ID: 17223834
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of drugs against dementia].
    Engedal K; Braekhus A; Gjerstad L
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1641-2. PubMed ID: 15229711
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cholinergic deficiency syndrome as an indicator for the cholinesterase inhibitors].
    Lemstra AW; Eikelenboom P; van Gool WA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2201-3. PubMed ID: 14640055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.